SCHEMBL1764056

SCHEMBL1764056

N=C(N)NC(=O)c1ccc(C2CCN(C(=O)c3ncco3)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD5 Q86SK9 2/20 0.41
SCD O00767 1/20 0.41
FAAH O00519 2/20 0.40
CHRNA4 P43681 2/20 0.40
LMNA P02545 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA7 P36544 1/20 0.40
PARP10 Q53GL7 2/20 0.39
FASN P49327 7/20 0.39
SLC6A7 Q99884 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12593492 0.79 FASN (0.39) FAAHCHRNA4CHRNB2CHRNB4CHRNA3
SCHEMBL1763096 0.78 PARP10 (0.63) PARP10CA12CA1CA2CA7
SCHEMBL1763401 0.75 SLC9A1 (0.47) SCD5SCDLMNAPARP10CA12
SCHEMBL1763921 0.75 SLC9A1 (0.48)
SCHEMBL1763347 0.74 CA12 (0.54) LMNAPARP10FASNCA12CA1
Hydrochloric Acid SCHEMBL8506097 0.70 HDAC8 (0.59) LMNAHDAC3HDAC1HDAC11HDAC8
SCHEMBL20758252 0.69 CHRNA4 (0.55) FAAHCHRNA4CHRNB2CHRNB4CHRNA3
SCHEMBL1763606 0.65 SLC9A1 (0.69)
SCHEMBL24011555 0.65 FAAH (0.54) FAAHCHRNA4CHRNB2CHRNB4CHRNA3
SCHEMBL7266574 0.65 ALDH1A1 (0.48) LMNACA2HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118262-A1 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-19 US disclosed
US-20110118262-A1 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-19 US disclosed
US-20110118262-A1 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-19 US disclosed
WO-2010005783-A1 PYRROLIDINYL AND PIPERIDINYL COMPOUNDS USEFUL AS NHE-1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118262-A1 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors NHERF1, SLC9A1, SLC9A5 SCD5 3167/4885SCD 3399/4885FAAH 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.